ZOE Health Study: The Intermittent Fasting Study
The Intermittent Fasting ZOE Health Study: Effects on Hunger, Mood, Energy and Symptom Burden in a UK Cohort
1 other identifier
interventional
150,000
1 country
1
Brief Summary
The timing of food intake (chrononutrition) is emerging as a key regulator of circadian rhythm in metabolic organs. A wealth of research has been conducted on intermittent fasting, and time restricted eating (TRE) specifically, investigating the temporal patterns of diet (eating window, time of eating, time of largest energy intake) and their impact on disease risk, with overall beneficial impact on health. Studies have been conducted in a parallel or single arm design, while cross-over and the efficacy of TRE in ameliorating appetite and symptom burden within an individual remains unclear.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2022
CompletedFirst Posted
Study publicly available on registry
September 28, 2022
CompletedStudy Start
First participant enrolled
October 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 24, 2023
CompletedNovember 30, 2022
September 1, 2022
1 year
September 23, 2022
November 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
TRE window clock time
The chosen clock time for the TRE window (early, vs. middle, vs. late)
2 weeks
Habitual eating window clock time
The chosen clock time for the habitual eating window
1 weeks
Hunger
Hunger levels reported by visual analogue scale ("how hungry did you feel yesterday?"; 0-10; where 10 is the most hungry)
3 weeks (plus optional unlimited weeks)
Mood
Mood levels reported by visual analogue scale ("how was your mood yesterday?"; 0-10; where 10 is most positive)
3 weeks (plus optional unlimited weeks)
Energy
Energy levels reported by visual analogue scale ("how energetic did you feel yesterday?"; 0-10; where 10 is most energetic)
3 weeks (plus optional unlimited weeks)
Symptom burden
The self-reported symptom burden while completing both habitual and TRE phases
3 weeks (plus optional unlimited weeks)
Secondary Outcomes (3)
Body weight
3 weeks (plus optional unlimited weeks)
Gastrointestinal symptoms
3 weeks (plus optional unlimited weeks)
Eating habits
3 weeks (plus optional unlimited weeks)
Study Arms (1)
Self-controlled
EXPERIMENTALn-of-1 design. Participants complete a baseline habitual eating phase following by an intervention TRE phase.
Interventions
Participants are asked to follow a Time Restricted Eating regimen with eating window of ≤10 hours.
Eligibility Criteria
You may qualify if:
- Adults of 18 years and above, where the app has been approved for download from the Apple App and Google Play stores.
You may not qualify if:
- Unable to provide written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zoe Global Limitedlead
- King's College Londoncollaborator
Study Sites (1)
ZOE Limited
London, SE1 7RW, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tim Spector, Pr
Zoe Ltd, King's College London
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 23, 2022
First Posted
September 28, 2022
Study Start
October 24, 2022
Primary Completion
October 24, 2023
Study Completion
October 24, 2023
Last Updated
November 30, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share